Suven Pharmaceuticals Q4FY21 consolidated PAT at Rs. 83.11 Cr
Pharma

Suven Pharmaceuticals Q4FY21 consolidated PAT at Rs. 83.11 Cr

The company reported total income of Rs.1023.95 crores during FY 2020-21

  • By ICN Group | June 09, 2021

Suven Pharmaceuticals has reported total income of Rs.262.46 crores during the period ended March 31, 2021 as compared to Rs.279.77 crores during the period ended December 31, 2020. It reported total income of Rs.190.10 crores during the period ended March 31, 2020.

The company posted net profit of Rs.113.62 crores for the period ended December 31, 2020. It posted net profit of Rs.74.18 crores for the period ended March 31, 2020.

Suven Pharmaceuticals has reported total income of Rs.1023.95 crores during the 12 months period ended March 31, 2021 as compared to Rs.851.90 crores during the 12 months period ended March 31, 2020.

The company has posted net profit of Rs.362.34 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.317 crores for the 12 months period ended March 31, 2020.

Other Related stories

Startup

Chemical

Petrochemical

Digitization

Gas